Eyes 4 Lives has developed a unique yet effective AI software solution to minimize/prevent Digital Eye Strain (DES), a group of eye and vision-related problems caused by our addiction to cell phones, tablets, and computers. DES is currently affecting about 65% of the Americans and is one of the hottest topics in the eye care and ergonomic industries, particularly during the COVID-19 pandemic when just about everyone is staring at the electronic screens to work/learn remotely.
- We are the only effective solution that continuously monitors and nudges/coaches users of digital devices to better eye health.
- 12 patents issued in US, China, and Taiwan
- Collaboration with some of the largest original design manufacturers (ODMs) and original equipment manufacturers (OEMs) of digital devices.
The American Optometric Association reports that 10 million eye exams are performed annually in the United States due to vision problems related to computer use. Digital Eye Strain (DES) currently affects about 65% of the Americans due to frequent use of cell phones, computers, and tablets .
DES symptoms include:
- Dry/burning eyes
- Visual fluctuation
- Light sensitivity
- Neck/shoulder pain.
If ignored, these symptoms could potentially result in permanent damages to both the ocular and musculoskeletal systems. DES has quickly become one of the hottest topics in the eye care industry, especially during the COVID-19 pandemic when learning and working remotely has increased dramatically.
Eyes 4 Lives, Inc.’s initial proof-of-concept product, Dr. i-Coach®, is a patented sensor and software package that utilizes advanced AI and sits on top of a laptop or computer to continuously monitor the following 5 key risk factors for Digital Eye Strain:
- Blink Analyzer - warns the user if their blink rate gets too low, reducing dry eyes.
- Time & Break Reminder - tracks computer usage and reminds the user to take a short break, allowing the user’s eyes to relax.
- Distance Monitor - reminds the user if they are sitting too close to the screen, potentially causing additional straining and nearsightedness.
- Posture Monitor - warns the user if they are sitting at an inappropriate height, creating neck and back pain.
- Ambient Lighting - warns the users when the room/sounding lighting condition is not ideal.
When utilizing the embedded camera of future devices, Dr. i-Coach® nudges users to better digital device habits via prompts and alerts. Eyes 4 Lives coaches users on developing and maintaining proper sitting and screen use habits by providing instant summarized feedback and long term detailed scoring via proprietary metric, eyeQscore.
Users can easily see their electronic-device-using habits improve over time by checking the statistics page, or receive text/email alerts on their progress throughout the day. Dr. i-Coach is an easy way to add significant economic benefits to companies with large numbers of employees using computers daily.
We make money through two main facets, IP Licensing and SaaS Subscriptions.
Embedding software directly into firmware of integrated webcams.
$0.20 – $0.99 per device (based on volume)
$0.99 – $4.99 per month (based on features)
Freemium model of premium consumer features (free trial).
These numbers are based on devices shipped in 2019. From the suggestions given to us by the top ODM/OEM computer manufacturer in the world, our initial target is the top 10% premium computers market, with a 5% subscription/adaptation rate at the end of the freemium period.
Success To Date
- First mover advantage, R&D led to extensive patent portfolio
- Raised 2.8M seed from friend, family and patients
- Developed, produced and sold generation 1 external device.
- Successful small-scale clinical efficacy study at USC (10 participants).
- Pivoted to embedded cameras and utilizing advanced AI let to collaboration with:
- MOU with Intel Corporation
- R&D collaboration with world’s largest TV manufacturer
- LOI with Quanta Computer
- 2019 CES showcase with Quanta Computer
- 2021 CES showcase with Intel demoing E4L software on their latest platform
- Over 23 years of experience as an Optometrist
- 10 years research on Computer Vision Syndrome
- Keynote Speaker at NASA, National Ergonomic Council and ErgoExpo2018 on Digital Eye Strain
- First optometric intern selected for the 1996 Summer Olympic Games in Atlanta
- Doctor of Optometry, Pennsylvania College of Optometry
Use of Proceeds
If the offering's maximum amount of $1,000,000 is raised:
|Use||Value||% of Proceeds|
|Compensation for managers||$100,000||10.0%|
This is an offering of Common Stock, under registration exemption 4(a)(6), in Eyes 4 Lives, Inc.. This offering must raise at least $10,000 by May 1, 2021 at 12:59am ET. If this offering doesn’t reach its target, then your money will be refunded. Eyes 4 Lives, Inc. may issue additional securities to raise up to $1,000,000, the offering’s maximum.
If the offering is successful at raising the maximum amount, then the company’s implied valuation after the offering (sometimes called its post-money valuation) will be:
These financial statements have been reviewed by an independent Certified Public Accountant.
The Offering Statement is a formal description of the company and this transaction. It’s filed with the SEC to comply with the requirements of exemption 4(a)(6) of the Securities Act of 1933.
We’re also required to share links to each of the SEC filings related to this offering with investors.
Understand the Risks
Be sure to understand the risks of this type of investment. No regulatory body (not the SEC, not any state regulator) has passed upon the merits of or given its approval to the securities, the terms of the offering, or the accuracy or completeness of any offering materials or information posted herein. That’s typical for Regulation CF offerings like this one.
Neither Netcapital nor any of its directors, officers, employees, representatives, affiliates, or agents shall have any liability whatsoever arising from any error or incompleteness of fact or opinion in, or lack of care in the preparation or publication of, the materials and communication herein or the terms or valuation of any securities offering.
The information contained herein includes forward-looking statements. These statements relate to future events or to future financial performance, and involve known and unknown risks, uncertainties, and other factors, that may cause actual results to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties, and other factors, which are, in some cases, beyond the company’s control and which could, and likely will, materially affect actual results, levels of activity, performance, or achievements. Any forward-looking statement reflects the current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. No obligation exists to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
- Jun 27, 2023Dear Shareholders, As some of you might have...
Dear Shareholders, As some of you might have known, we had been working with a leading semiconductor chip manufacturer to license our algorithm as part of their global school district initiative. As of now, It looks like we have not won the licensing contract with them, as they have been completely silent this year. And because of this puzzling development, we had to part ways with our CEO, MR. Lars Nordenlund, and hit the restart button for the project. Rest assured, we will continue to work hard to find willing partners to bring our idea to market in a large scale, so every computer/cellphone/tablet users in the world could benefit from our algorithm designed to minimize Digital Eye Strain, Screen-Induced Dry Eyes and Childhood Myopia.
Dr. Roger Wu
- Mar 2, 2023This is just a quick announcement: We are...
This is just a quick announcement: We are currently working with a lawyer and CPA to devise the best restructuring, fundraising and capitalization strategies, and should be able to provide exact numbers within 2-3 weeks. The restructured firm will be registered in Delaware (Instead of California that’s currently registered). Thank you.
- Oct 20, 2022It is my honor and pleasure to announce that we...
It is my honor and pleasure to announce that we have successfully recruited Lars Nordenlund to be our new CEO to lead us in our battle against Digital Eye Strain and Childhood Myopia. Lars was the former Senior Director of Global ISV Partnership department at Microsoft, and CEO/Founder at Arcules, a division of Canon, Inc.. He is a global visionary thought leader with a successful track record of conceiving and delivering breakthrough growth strategies, corporate reinvention and business transformations. He has in the last twenty years been a leading authority on strategic change, disruptive innovation, digital transformation and design thinking, with special emphasis on the wonder and power to disrupt with technology, AI, IoT, enterprise software, cloud video, SaaS and media advertising. Welcome aboard!
- Jul 12, 2022I just wanted to provide everyone with a quick...
I just wanted to provide everyone with a quick update: We have recently finished shooting several educational videos about Childhood Myopia, Digital Eye Strain, etc., and sent them to a major microchip manufacturer for review. These videos will be used for their school district initiatives if approved. Thanks.
- Apr 26, 2022
- Mar 31, 2022Dear Eyes 4 Lives' Shareholders, I have some...
Dear Eyes 4 Lives’ Shareholders, I have some exciting news to share with you: First: we have successfully modified our software so it’s now able to run on Altek’s next-gen microchip. It’s been tested on the chip’s simulator currently. Second: we have signed a second NDA with a pharmaceutical company’s corporate VC division and entered due diligence process with them since 03/21/22. Thank you.
- Dec 8, 2021Dear E4L Shareholders, I like to wish everyone...
Dear E4L Shareholders, I like to wish everyone a happy and healthy holiday season! We have made an internal decision at E4L this month. Starting December of 2021, Intel is being moved down from our priority strategic partner list. As a small startup, we simply can’t afford to sit around and wait for them to decide on their next move. Our new priority is now working with Altek Corporation’s latest M1 microchip. Altek had just provided us with details of the chip design and we plan on modifying our software to accommodate it. Estimated time required is 3 months for the first demo. Thank you.
- Jun 20, 2021Dear Eyes 4 Lives, Inc's shareholders: We have...
Dear Eyes 4 Lives, Inc’s shareholders: We have just recently concluded our first raise at Netcapital and received the funds. I want to thank everyone for your trust and sharing our vision to build a healthier device usage habit for current and future generations. Your shares can be viewed on your Netcapital dashboard. Thank you for your patience. Regards Dr. Roger Wu
- Jun 2, 2021
- May 1, 2021Primary offering finalized, sellingsharesSold $0.10 for a total of $17,619.10shares at
- Apr 22, 2021
- Mar 29, 2021
- Mar 1, 2021We have officially signed an agreement with...
We have officially signed an agreement with Independent Investment Bankers Corp. (IBB) and Park Road Advisors to lead our capital raising process today.
- Feb 25, 2021Hi Everyone, my name is Dr. Roger Wu and I am...
Hi Everyone, my name is Dr. Roger Wu and I am the Founder of Eyes 4 Lives, Inc.. To begin, I like to thank everyone who had already made the commitment to invest in this unique yet meaningful project. As a clinician, I am seeing more patients with eye problems caused by our reliance on smart phones, tablets, and computers. That’s why this company was created, and we currently offer the only full-featured solution to this growing problem called Digital Eye Strain. Our goal to commercialize later this year will be one step closer with this investment, and thank you for joining our mission to make a lasting impact!
- Feb 10, 2021We have just been invited by one of the biggest...
We have just been invited by one of the biggest vision insurance companies in the U.S., VSP, to present our unique project at their Digital Eye Strain Innovation Showcase on 03/01/2021.
- Jan 29, 2021Primary offering of $0.10shares at
- Jan 29, 2021
Ask a Question
Proofread your comment before submitting: once it's posted, you can’t edit or delete it. For the fastest help with the web site, email firstname.lastname@example.org instead of commenting.